KIDS
OrthoPediatrics Corp.NASDAQHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
1.08
P/S
1.70
EV/EBITDA
-54.79
DCF Value
$-27.71
FCF Yield
-4.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
73.1%
Operating Margin
-12.3%
Net Margin
-16.8%
ROE
-11.3%
ROA
-7.6%
ROIC
-6.1%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $61.6M | $-10.1M | $-0.43 |
| FY 2025 | $236.3M | $-39.6M | $-1.69 |
| Q3 2025 | $61.3M | $-11.8M | $-0.50 |
| Q2 2025 | $61.1M | $-7.1M | $-0.30 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
1.16
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.